Circassia has issued a notice of option exercise to AstraZeneca related to US commercial rights of Tudorza. The company intends to complete the option exercise by the end
The post Circassia to acquire full US rights of AstraZeneca’s COPD treatment Tudorza appeared first on Pharmaceutical Business review.